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Abstract
In polytrauma, injuries that may be surgically treated under regular circumstances due to a systemic infl ammatory response become life-
threatening. Th e infl ammatory response involves a complex pattern of humoral and cellular responses and the expression of related factors 
is thought to be governed by genetic variations. Th is aim of this paper is to examine the infl uence of interleukin (IL)  single nucleotide poly-
morphism (SNP) -C/G and -G/A on the treatment outcome in severely injured patients. Forty-seven severely injured patients were 
included in this study. Patients were assigned an Injury Severity Score. Blood samples were drawn within  h after admission (designated day 
) and on subsequent days (, ,  hours and days) of hospitalization. Th e IL- levels were determined through ELISA technique. Polymor-
phisms were analyzed by a method of Polymerase Chain Reaction-Restriction Fragment Length Polymorphism (PCR). Among subjects with 
diff erent outcomes, no statistically relevant diff erence was found with regards to the gene IL- SNP-G/C polymorphism. More than a half 
of subjects who died had the SNP-G/C polymorphism, while this polymorphism was represented in a slightly lower number in survivors. 
Th e incidence of subjects without polymorphism and those with heterozygous and homozygous gene IL- SNP-G/A polymorphism did 
not present statistically signifi cant variations between survivors and those who died. Th e levels of IL- over the observation period did not 
present any statistically relevant diff erence among subjects without the IL- SNP- or IL-  SNP - gene polymorphism and those who 
had either a heterozygous or a homozygous polymorphism. ©  Association of Basic Medical Sciences of FB&H. All rights reserved
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INTRODUCTION
Trauma is the leading cause of death in the developed soci-
eties among the population under  years of age, and it is 
the th cause of death in general, which therefore makes the 
understanding of pathophysiological mechanisms exception-
ally important []. In polytrauma, injuries that may be surgi-
cally treated under regular circumstances – due to system 
overload - become life-threatening. Direct or indirect con-
sequences of trauma (”trauma load”, ”antigenic load”) over-
come the defence mechanisms of an organism. A physiologi-
cal ”host defence response« switches into a self-destructive 
”host defence failure disease”, leading to the immune system 
shutdown, and subsequently to sepsis and progressive mul-
tiple organ dysfunction syndrome (MODS), as the most se-
vere complication of polytrauma that usually involves two 
or more organ systems with the presence of alerted function 
in acutely ill patients such that homeostasis cannot be main-
tained without intervention []. Th e infl ammatory response 
involves a complex pattern of humoral and cellular responses 
and the expression of related factors is thought to be gov-
erned by genetic variations. Cytokines are integral compo-
nents of the host immune response to trauma or infection [].
Interleukin  (IL-) is a cytokine with both pro- and anti-
inflammatory properties and its release into peripheral 
blood seems to be an early marker of injury severity fol-
lowing trauma. Interleukin  is a -kDa glycoprotein that 
is produced by numerous types of cells, particularly lym-
phocytes, to which it owes its name, and by fi broblasts and 
monocytes as well. It exhibits various biological effects, 
including the activation of B and T lymphocytes, induc-
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tion of acute-phase protein synthesis in the liver, modula-
tion of hematopoiesis, and it belongs to the groups of both 
pro- and anti-infl ammatory cytokines. In addition, it acts as 
a pyrogen, it activates the coagulation system, and in vitro 
IL- it suppresses the synthesis of TNF-α and IL-β [, ]. 
Th e IL- gene is located on chromosome  and several poly-
morphisms have been reported. Th e most frequently studied 
polymorphism is the single nucleotide polymorphism (SNP) 
- C and -G in the promoter region, which has been 
associated with transcription rates of IL-. Th e incidence of 
IL--C alleles is approximately  among the general 
population, and it decreases in patients suff ering from infl am-
matory diseases like juvenile rheumatoid arthritis []. Th e 
transfection of IL--C alleles into HeLa cells in vitro has 
resulted in a decrease in IL- production compared to that 
of IL- -G []. Additional polymorphisms may aff ect the 
IL- transcription as well, with complex interaction among 
certain haplotypes [], but the published studies in that re-
gard have been few. As far as the -G/A single-nucleotide 
polymorphism (SNP) is concerned, relevant literature pro-
vides substantially less information on its clinical importance.
This aim of this paper is to examine the influence of 
IL- single nucleotide polymorphism (SNP) -C/G 
and single nucleotide polymorphism (SNP) -G/A 
on the treatment outcome in severely injured patients.
MATERIALS AND METHODS
Patients 
Forty-seven severely injured patients were included in this 
study. All patients were admitted in the intensive care unit 
due to the trauma severity. Patients were assigned an Injury 
Severity Score (ISS) [] by independent evaluators. Exclu-
sion criteria were (I) age of older than  years or younger 
than  years, (II) admission more than  h after trauma or 
secondary admission, (III) penetrating injuries, and (IV) any 
chronic illnesses. Injuries of the various body regions (head 
and neck, face, thorax, abdomen, extremities, and skin) 
were classifi ed by usingthe Abbreviated Injury Scale (AIS) 
[]. Th e clinical course was monitored prospectively in all 
patients. Patients requiring surgical intervention received 
standard surgical care and postoperative intensive care. We 
assumed that blood transfusions that were submitted to pa-
tients had no signifi cant eff ect on the results of the study due 
to the same amount of blood given to the injured patients.
Blood samples were drawn within h after admission (des-
ignated day ) and on subsequent days (, ,  hours 
and  days) of hospitalization. Blood ( ml) was collected 
in plastic tubes (NH-heparin tube; Sarsted, Nümbrecht, 
Germany) along with the routine baseline laboratory 
work-up and was immediately used for stimulation ex vivo. 
DNA isolation
Genomic DNA was isolated from peripheral blood with 
QIAampDNA Mini Kit (Qiagen GmbH, Hilden, Germany), 
and stored at -°C.
Gene variants detection
All analyzed polymorphisms and primers used for 
their detection, are shown in Table . Polymorphisms 
are denoted by both, common nomenclature (used 
through the whole article), and HGVS nomenclature. 
Interleukin- G-C and G-A detection
The genotyping of the polymorphisms in IL- promoter 
G-C (rs) and G-A (rs) was per-
formed using PCR-RFLP technique as previously described 
[]. A -bp fragment containing both polymorphic 
sites (- and -) was amplified using one primer set. 
Th e PCR conditions were: denaturation step at °C for  
min,  cycles of amplifi cation (°C for  sec, °C for  
sec and °C for  sec) and elongation step of  min at 
°C. Th e obtained PCR product was digested with Hin II 
and Fok I (MBI Fermentas, Vilnius, Lithuania). Digestion 
with Hin II (G-C) gave the following pattern (in base 
pairs): ++ for GG genotype, ++++ 
for GC genotype and ++ for CC genotype. Diges-
tion with Fok I (G-A) gave fragments of the following 
length (in base pairs):  for the GG genotype, ++ 
for the GA genotype and + for the AA genotype.
Statistical analysis
Statistical analyses were performed using the SPSS soft-
ware v.. (SPSS Inc., Chicago, IL,USA). Descriptive 
data for all groups and variables were expressed as mean 
± standard deviation (SD), mediana, minimum and maxi-
mum for continuous measures, or percent of a group for 
discrete measures. Categorical data were analyzed using 
Gene
Polymorphism
Primers: in 5'-3' direction, Forward- F, Reverse- R
Common nomenclature HGVS nomenclature
IL-6
G-174C NC_000007.13:g.22766645C>G/NM_000600.3:c.-116-121C>G F: GGAGTCACACACTCCACCT 
R: CTGATTGGAAACCTTATTAAG
G-597A NC_000007.13:g.22766221A>G/NM_000600.3:c.-116-545A>G
TABLE 1.  Analyzed gene polymorhisms
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the Pearson chi-square test. A normal distribution was 
tested using the Koglomorov-Smirnov test. If the data 
were normally distributed, the t-test was used. Non-para-
metric data were analyzed using the Mann Whitney U 
test, and Kruskal Wallis test. Diff erences were considered 
significant when the p value was less than . (p<.).
Th is study received an approval from the local ethics committee.
RESULTS
A total of forty-seven severely injured patients were in-
cluded in the fi nal study. Demographic features of patients 
involved in this research were analyzed. The mean age 
of patients was .±;  patients were male and  fe-
males. Patients were stratifi ed acording to outcome to sur-
vivors (mean age .±. male patients and  female) 
and non survivors (mean age . ±. male and  female 
patients). Th ere was no signifi cant statistical diff erence be-
tween these two groups acording to gender and age (p>.)
Th e main mechanism of injury was traffi  c, followed by fall 
and assault. Th e non survivors were the most frequent in the 
group of patients which were injuried as motorcycle driv-
ers. Using χ test no statistically signifi cant diff erence was 
recorded between survivors and non-survivors (p=.).
Th e Injury Serverity score (ISS) provided an over all score 
for patients with multiple injuries. Each injury was as-
signed an Abberviated Inury Scale score (AIS) allocated to 
one of six body regions (Head, Face, Chest, Abdomen, Ex-
tremities, External). Analysing the AIS and ISS score we 
observed statistically significant higher values of ISS and 
AIS for head and neck in patients with lethal outcome usin 
Mann Whitnez U-test (p=. and ., respectively).
Th e IL- value analysis during the observation period yielded 
a statistically relevant difference (Friedman test; p=.). 
Th e highest values with statistical relevance were measured 
on admission (Wilcoxon test; p=.). Th e IL- level mea-
surement after h resulted in statistically relevant lower val-
ues compared to those on admission, but these values were 
higher in turn from the values obtained after h (Wilcoxon 
test; p=.), h (Wilcoxon test; p=.) and after  days 
(Wilcoxon test; p=.). For values of IL- measured h 
and h after admission (Wilcoxon test; p=.), h and  
days (Wilcoxon test; p=.) and h and  days after ad-
mission, no diff erence was found between them (Figure ).
A statistically relevant change in IL- value over the seven-
day observation period was found both in survivors (Fried-
man test; p=.) and in subjects who died (Freidman 
test; p=.). In both of these subject groups, a statistically 
relevant drop in the values was found (Figure ). Among 
subjects who had a different outcome, no statistically rel-
evant diff erence was noted in the initial  hours, while the 
cytokine levels on day  with respect to those obtained h 
after admission were higher in subjects who died (Table ).
Outcome
Signifi cance
Survivor Non-survivor
IL-6 
X±SD 
(Med; 
min-
max)
0h 675.7±722.9 (457.8;53.7-2527.5)
598.6±388.8 
(448.3; 157.4-1669.5)
bp=0.181
24h 187.34±184.6 (107.2; 31.6-813.9)
955.9±1880.9 
(277.3; 38.4-7427.6)
bp=0.100
48h 113.01±84.37 (78.03; 24.3-277.7)
470.0±803.8 
(155.9; 17.8-2871.3)
bp=0.246
72h 72.05±52.97 (62.4; 24.8-262.4)
233.26±274.1
(140.3; 28.86-981.8)
bp=0.033*
7. day 59.0±75.79 (29.87; 11.4-344.2)
188.3±181.3 
(102.6; 36.4-718.5)
bp=0.000*
TABLE 2.  IL-6 levels measurements according to outcome
*statistically signifi cant; at- test; bMann Whitney U test
FIGURE 1.  The IL-6 level measurements
FIGURE 2.  IL-6 levels measurements according to outcome
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Subjects without the IL- SNP-G/C gene polymorphism 
(.) and those with heterozygous polymorphism (.) 
were represented in closely equal number, while trauma pa-
tients with homozygous polymorphism were represented in 
a statistically signifi cantly lower number (χ-test; p=.).
Somewhat more than a half of subject did not have the 
gene IL- SNP-G/A polymorphism, approximately  
had heterozygous polymorphism, while about  had 
homozygous polymorphism. The subjects with homo-
zygous polymorphism were statistically significantly less 
represented than the patients without polymorphism or 
those with heterozygous polymorphism (χ-test; p=.).
Among subjects with different outcomes, no statisti-
cally relevant difference was found with regards to the 
gene IL- SNP-G/C polymorphism (Table ). More 
than a half of subjects who died had the SNP-G/C 
polymorphism, while this polymorphism was repre-
sented in a slightly lower number in survivors (Figure ).
Th e incidence of subjects without polymorphism and those 
with heterozygous and homozygous gene IL- SNP-G/A 
polymorphism did not present statistically signifi cant varia-
tions between survivors and those who died (Figure ). 
Slightly more than a half of subjects who survived had no 
polymorphism of this gene, close to a third of subjects had 
heterozygous polymorphism, while  of subjects had 
homozygous polymorphism. In subjects who died, some-
what more than a half had the gene IL- SNP-G/A 
polymorphism, approximately  had heterozygous, 
while the remaining . had homozygous form (Figure ). 
The IL- levels over the observed period of measure-
ment did not present a statistically significant differ-
ence between the subjects without the gene IL-SNP-
G/C polymorphism and those with heterozygous 
and homozygous polymorphism (Table , Figure ).
No statistically relevant diff erence in IL- levels measured 
on admission, h, h, h and seven days after admis-
sion between the subjects without the gene IL- SNP-
Outcome
Signifi cance
Survivor Non-survivor
IL-6 SNP
-174G/C 
n (%)
No Polymorphism 
(GG) 13 (50.0%) 9 (42.9%)
ap=0.329Heterozygous Poly-morphism (GC) 9 (34.6%) 11 (52.4%)
Homozygous Poly-
morphism (CC) 4 (15.4%) 1 (4.8%)
IL-6 SNP
-596G/A
n (%)
No Polymorphism 
(GG) 14 (53.8%) 10 (47.6%)
ap=0.844Heterozygous Poly-morphism (GA) 9 (34.6%) 9 (42.9%)
Homozygous Poly-
morphism (AA) 3 (11.5%) 2 (9.5%)
TABLE 3.  Gene polymorphism incidence according to outcome
*statistically signifi cant; aχ2- test
Cytokine and Measurement Time
IL-6 SNP-174G/C Gene
Signifi cance
No Polymorphism (GG) Heterozygous Polymorphism (GC)
Homozygous 
Polymorphism (CC)
IL-6 
X±SD  
(Med; min-max)
0h 532.76±387.41(472.2; 53.7-1669.2)
1356.22±2730.31 
(450.78; 141.2-9780.5)
1360.21±1003.4 
(1648.8;244.1-2187.7)
bp=0.529
24h 339.1±427.26(184.6; 31.6-1480.4)
843.4±1946.4
(184.5; 38.4-7427.6)
154.7±177.99
(61.8; 42.1-461.8)
bp=0.452
48h 166.79±226.8 (83.95; 17.8-966.8)
433.08±819.17  
(165.15;28.28-2871.25)
101.51±72.12 
(72.38;38.42-190.42)
bp=0.573
72h 138.49±175.35 (66.19; 24.8-680.58)
159.86±245.79  
(81.04; 27.64-981.84) 
70.63±36.67  
(87.1; 28.86-108.06)
bp=0.651
7. day 157.61±182.67 (92.73;11.44-718.47)
69.87±51.65  
(62.78; 20.82-213.7)
37.77±31.53  
(28.82; 16.49-92.78) bp=0.177
Cytokine and Measurement Time
IL-6 SNP-596G/A Gene
Signifi cance
No Polymorphism (GG) Heterozygous Polymorphism (GA)
Homozygous 
Polymorphism (AA)
IL-6 
X±SD  
(Med; min-max)
0h 599.49±528.35  (472.2; 53.7-2187.7)
1592.1±2956.3  
(478.3; 173-9780.5)
678.06±842.3 
(244.1;141.2-1648.8)
bp=0.708
24h 325.66±409.37  (184.6; 31.6-1480.4)
875.6±2010.26  
(133.6; 38.4-7427.6)
181.0±193.96 
(110.1; 42.1-461.8)
bp=0.755
48h 170.19±215.07  (106.4; 17.8-966.8)
447.23±848.18  
(138.36; 28.3-2871.2)
85.22±71.88  
(56.0; 38.4-190.4)
bp=0.575
72h 137.54±166.03  (71.7; 24.8-680.6)
160.63±255.81  
(79.1; 27.6-981.8)
61.27±34.77  
(60.5; 28.9-95.3)
bp=0.598
7. day 147.29±176.08  (88.8; 11.4-718.5)
68.12±53.54  
(56.98; 20.8-213.7)
42.72±34.09  
(30.8; 16.5-92.8)
bp=0.369
TABLE 4.  Cytokine IL-6 levels and genetic polymorphism
* statistically relevant; bKruskal Wallis test
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G/A polymorphism and with the homozygous and 
heterozygous polymorphism (Table ). The lowest levels 
of this interleukin measured during the observation pe-
riod in the polytrauma group were found in subjects with 
the homozygous polymorphism of this gene (Figure ).
DISCUSSION
The term polytrauma involves life-threatening injuries 
to at least two regions of the body []. The incidence 
of polytrauma in the under- age group is . and 
it represents the most frequent cause of death [-]. 
The provision of professional and prompt care direct-
ly affects mortality, morbidity and functional recovery. 
A complicated system of cellular interactions and media-
tors governs the “generalized inflammatory syndrome” in 
order to induce recovery and control an invasion by ex-
ternal organisms. In some cases of severe trauma, the in-
flammatory process goes out of control and vital tissue 
that has not been initially injured sustains damage. As 
numerous complex mediators and cellular systems are 
involved, the interpretation of such multiple interac-
tions and their changes over time is highly complicated. 
IL- production is stimulated by TNF-α and IL-, which was 
proven in experimental and clinical studies, and it may be 
found in plasma after these two cytokines [, ]. Experi-
mental studies have showed that a high concentration of IL- 
is in correlation with the poor outcome of trauma and sepsis 
[]. Jastrow et al. [] in their analysis of cytokine concentra-
tion in serum every  hours,  hours after trauma, intended 
to identify a cytokine that could be used as a predictor for 
the development of MODS. Th is group of authors analyzed 
a number of cytokines and they came to the conclusion that 
IP-, MIP-β, IL-, IL-, IL-Ra and eotaxin may be used to 
FIGURE 3.  Gene IL-6 SNP-174G/C polymorphism in groups with 
diff erent treatment outcomes
FIGURE 4.  Gene IL-6 SNP-596G/A polymorphism in groups with 
diff erent treatment outcome
FIGURE 5.  Gene IL-6SNP-174G/C polymorphism and IL-6 levels FIGURE 6.  Gene IL-6SNP-596G/A polymorphism and IL-6 levels
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predict the development of MODS, as they exhibited higher 
levels in the period from  to  hours after trauma compared 
to the patients who did not get MODS. Considering the 
IL- levels in the period of - hours after trauma, the AU-
ROC was ., cut-off  value ., sensitivity , while 
the positive predictive value was at , and in the - 
hour period after trauma, this value was reduced by -.
Other authors have showed that the increased levels of IL- 
after trauma may be used as predictors for the development 
of MODS. It was determined that the increased IL- values 
were measured on days  and  in correlation with the devel-
opment of MODS []. Particular authors described a signifi -
cant increase in IL- on days  and  and the majority agrees 
that the sensitivity of this cytokine for the prediction of sys-
temic complications development is reduced after  days [].
In our group, the IL- levels were higher in patients 
who died and exactly on day  of observation, the 
value exhibited a statistically relevant difference. 
Th is SNP G>C at position - in the promoter region of IL- 
gene is related to the prevalence, incidence and/or progno-
sis of various diseases like Alzheimer’s disease, atherosclero-
sis, cardiovascular disease, carcinomas, insulin-independent 
diabetes mellitus, osteoporosis, sepsis and systemic complica-
tions of juvenile chronic arthritis [-]. Th e G allele of - 
SNP is coupled with the increase in transcriptional response 
to stimuli like endotoxins or IL-β in vitro [, ], while 
the studies that examined in vivo the -G>C promoter 
polymorphism in correlation with the plasma levels of IL- 
yielded contrasting results. In the fi rst study, Fishman et al. 
[] demonstrated that the unstimulated levels of IL- were 
coupled with the G allele of healthy individuals. Since then, 
opposing results related to the combination of IL- and SNP-
G>C in healthy and ill individuals have been obtained 
[-]. Th us, the plasma levels of IL-, stimulated through 
coronary artery bypass surgery, correlated both with the G 
allele [] and with the C allele [], depending on the blood 
sample drawing after the procedure, while the administra-
tion of endotoxins in healthy volunteers did not confi rm the 
existence of a relation between the IL- concentration and 
-G>C polymorphism []. Banermo et al. [] studied the 
role of -SNP in the induction of plasma concentrations of 
IL- in vivo. Th ey exposed healthy individuals who had the 
homozygous allele to a standardized infl ammatory stimulus 
by administering a salmonella typhoid vaccine. Th ey came to 
the conclusion that the G allele -G>C SNP homozygotes 
had a stronger IL- infl ammatory response to s. typhoid vac-
cination than the C allele homozygotes. Th e diff erence was 
not observed in the serum concentration of TNF-α and IL-β, 
which was explained by the fact that this vaccine is an infl am-
matory stimulus of low potential and a weaker stimulator of 
cytokine production. Other studies [,] have showed that 
the G allele - SNP is coupled with the increased transcrip-
tion upon endotoxin and IL-β stimulation. Further ex vivo 
studies of full healthy lipopolysaccharide-stimulated blood 
have showed that the haplotypes of IL- promoters, includ-
ing the G allele, are related to the higher levels of IL- []. 
Th ree studies examined the role of IL- -G>C SNP in the 
plasma IL- response in vivo [-]. Brull et al. [] have 
showed that as opposed to in vitro and ex vivo studies, the pa-
tients with homozygous C allele have higher plasma levels of 
IL- up to six hours after CABG stimulation, while a study by 
Burzotta et al. [] has demonstrated that CABG stimulation 
in patients with the G allele induces higher concentrations of 
IL- after  and h. Th e conclusion of the third study in vivo 
is that there is no signifi cant diff erence in the plasma levels 
of IL- in diff erent genotypes after intravenous endotoxin ad-
ministration []. No adequate explanation for such diverging 
results has been found, although the diff erent eff ects caused 
by the infl uence of various stimuli on the IL- promoter can-
not be ruled out, while a possible answer may be the lack of a 
functional relevance of -G>C SNP. Arguments speaking 
against this are the results of research of relation between the 
G allele and survival of sepsis []. It has been demonstrated 
that the G allele is related to the better survival of sepsis, but 
not to the incidence of sepsis, which is an indicative of the 
fact that an increased response of IL- in G allele is benefi cial 
when individuals are exposed to an acute infection. On the 
other hand, an increased response of IL- combined with the 
G allele may be harmful when it comes to the development 
of chronic diseases like the insulin-independent diabetes mel-
litus and atherosclerosis, considering that the repeated stimu-
lation with minor stimuli increases the infl ammatory stress. 
For example, it is proven that the insulin resistance is related 
to the G allele []. However, even the polymorphisms of 
other genes must be taken into account, as other studies have 
showed that the C allele, when combined with TNF-α SNP, is 
also related to the development of insulin-independent dia-
betes mellitus []. Several studies have concluded that the 
IL- is of key importance for the development of atheroscle-
rosis, where all but one study [] suggested that the G allele 
was related to the atherosclerosis [, , ]. In addition, sev-
eral studies pointed to the important role of IL- in bone den-
sity regulation in pre- and postmenopausal women, as well as 
in healthy men [, ]. Th e results were that the individuals 
with C allele had greater bone density when compared to the 
individuals with G allele. One explanation could be that the 
prolonged high levels of IL- induced by infections and other 
chronic conditions may cause the loss of bone mass [, ]. 
It appears that it is not only the -G>C SNP that aff ects the 
expression of IL- and its production as a response to stim-
uli. In vitro and in vivo studies have showed that haplotype 
-G>C, -AnTn, -G>C and -G>A polymorphisms 
 Bosn J Basic Med Sci 2014; 14 (2): 116-117
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aff ect the IL- concentration []. Haplotype analysis demon-
strated that the presence of at least two out of three common 
haplotypes, including -G, correlated with the increased 
IL- levels compared to the presence of only one common 
haplotype, -C included. It is interesting to note that this 
study showed that individuals with GG haplotype had lower 
IL- levels, which corresponds to the results obtained by Kel-
berman et al. [], and it points to the modulating infl uence 
of AnTn on IL- response within the -G>C SNP. As far 
as IL- SNP- G>C and IL- SNP- G>A, Terry et al. 
determined that the IL- transcription positively correlates 
with these polymorphisms, although the other polymor-
phism that occurs is in a synergy as far as the eff ect on the 
promoter activity is concerned. []. Other studies showed 
that the -A allele constitutes a potent counterbalance of 
the - C allele, however the limitation to this study was 
that the information on the origin of IL- were not available 
[]. Due to confl icting results obtained, further investigation 
both in vitro and in vivo is required for the purpose of learn-
ing more and explaining the IL- expression and production. 
In an analysis of SNP polymorphism IL- SNP- and 
SNP- in a group of polytrauma patients in our series, no 
statistically relevant diff erence in the frequency of a particu-
lar outcome, although the - polymorphism was less rep-
resented in the group of polytrauma patients who survived. 
In the group of polytrauma subjects, the levels of IL-, over 
the -day period of observation and cytokine measurement, 
did not produce a statistically relevant diff erence between 
the subjects who did not have the IL - gene polymor-
phism and those who had a heterozygous or homozygous 
polymorphism. Th e lowest levels of this interleukin in the 
-day observation period were measured in a subject from 
the group of polytrauma patients, and that subject had a SNP 
- IL- of this gene in a homozygous form. In the group 
of critically ill surgical patients, a statistically signifi cant dif-
ference, both for the gene IL- SNP- and SNP- gene 
polymorphism, was not observed among subjects who had 
diverse outcomes. The levels of IL- over the observation 
period did not present any statistically relevant diff erence 
among subjects without the IL- SNP- or IL-  SNP - 
gene polymorphism and those who had either a hetero-
zygous or a homozygous polymorphism (Figures  and ).
Furthermore, other polymorphisms may aff ect the IL- tran-
scription with a complex interaction among certain haplo-
types [], although few relevant studies have been published 
thus far. 
CONCLUSION
Based on the results of our study, we concluded that pre-
sensce of IL- polymorphism (SNP- or -) have no 
influence to production of IL- and due to this inflamma-
tory response to severe trauma, but future studies with more 
subjects included are necessary to clarify the mechanism 
of injury and patophysiological response to severe trauma. 
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